Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis. by Prolong Pharma | Jul 1, 2020 | Publications
Microvascular and Systemic Impact of Resuscitation with PEGylated Carboxyhemoglobin-Based Oxygen Carrier or Hetastarch in a Rat Model of Transient Hemorrhagic Shock. by Prolong Pharma | Apr 1, 2020 | Publications
Artificial Blood: The History and Current Perspectives of Blood Substitutes by Prolong Pharma | Mar 1, 2020 | Publications
Alternatives to Transfusion: A Case Report and Brief History of Artificial Oxygen Carriers by Prolong Pharma | Mar 1, 2020 | Publications
The effect of SANGUINATE® (PEGylated carboxyhemoglobin bovine) on cardiopulmonary bypass functionality using a bovine whole blood model of normovolemic hemodilution by Prolong Pharma | Jan 1, 2020 | Publications
Microvascular and systemic responses to novel PEGylated carboxyhaemoglobin-based oxygen carrier in a rat model of vaso-occlusive crisis. by Prolong Pharma | Dec 1, 2019 | Publications
